Roflumilast

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1016 publications

Renoprotective effect of roflumilast against amikacin- induced nephrotoxicity: upregulation of Nrf2 signaling, inhibition of cytokines, and renal apoptosis.

Renoprotective effect of roflumilast against amikacin- induced nephrotoxicity: upregulation of Nrf2 signaling, inhibition of cytokines, and renal apoptosis.

Journal: Drug and chemical toxicology

Published: June 22, 2026

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

Journal: The Journal of dermatological treatment

Published: June 11, 2026

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

Journal: The Journal of dermatological treatment

Published: June 11, 2026

Restoring access to long-term social recognition memories disrupted by sleep deprivation.

Restoring access to long-term social recognition memories disrupted by sleep deprivation.

Journal: Science advances

Published: June 10, 2026

Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitis.

Emerging topical nonsteroidal therapies in pediatric dermatology: atopic dermatitis, psoriasis, alopecia areata, vitiligo, and seborrheic dermatitis.

Journal: Current opinion in pediatrics

Published: June 04, 2026

The Treatment of Perioral (Periorificial) Dermatitis With Topical Roflumilast 0.3% Cream: An Illustrative Case Study With Rapid Onset and Prolonged Remission.

The Treatment of Perioral (Periorificial) Dermatitis With Topical Roflumilast 0.3% Cream: An Illustrative Case Study With Rapid Onset and Prolonged Remission.

Journal: The Journal of clinical and aesthetic dermatology

Published: June 04, 2026

Case Series: Successful Management of Refractory Plaque Psoriasis With Combined Laser Therapy and Topical Roflumilast in 2 Patients.

Case Series: Successful Management of Refractory Plaque Psoriasis With Combined Laser Therapy and Topical Roflumilast in 2 Patients.

Journal: The Journal of clinical and aesthetic dermatology

Published: June 04, 2026

Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients.

Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients.

Journal: Journal of drugs in dermatology : JDD

Published: June 03, 2026

Topicals for Psoriasis: Classical Drugs, New Concepts, and New Medications.

Topicals for Psoriasis: Classical Drugs, New Concepts, and New Medications.

Journal: The Journal of rheumatology

Published: June 01, 2026

Ten specific updates for the Mexican atopic dermatitis guidelines, GUIDAMEX 1.1.

Ten specific updates for the Mexican atopic dermatitis guidelines, GUIDAMEX 1.1.

Journal: Boletin medico del Hospital Infantil de Mexico

Published: May 21, 2026

Atopic dermatitis Yardstick: a new era of topical and systemic treatments.

Atopic dermatitis Yardstick: a new era of topical and systemic treatments.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: April 12, 2026

Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion.

Roflumilast Enhances Liraglutide's Atrial Natriuretic Peptide-Dependent Suppression of Adrenal Aldosterone Secretion.

Journal: International journal of molecular sciences

Published: March 31, 2026

Showing 1-12 of 1,016

Last Updated: 06/30/2026